Robert E. Dudley, Ph.D., has served as our Chief Executive Officer, President and Chairman of our board of directors since February 2004. Dr. Dudley has significant development, regulatory and commercial experience in the testosterone (T) replacement field. During his tenure as an executive at Unimed Pharmaceuticals, Inc., he led the discovery, development and FDA regulatory approval and launch of AndroGel®, the first T-gel product, which today remains the market-leading T-replacement therapy nearly a decade after its launch. Prior to founding Clarus, Dr. Dudley served as President, Chief Executive Officer, and Director of Anagen Therapeutics, Inc., from 2001-2003. He served as President, Chief Executive Officer and Director of Unimed Pharmaceuticals, Inc., from 1999 to 2001. From 1994 to 2001, Dr. Dudley held several senior-level executive positions at Unimed Pharmaceuticals, Inc., a public company acquired by Solvay Pharmaceuticals in 1999. Dr. Dudley received his B.S. in Biology from Pepperdine University, Seaver College, his M.S. in Biology from University of New Mexico, and his Ph.D., with honors, in Pharmacology and Toxicology from the University of Kansas School of Medicine. Dr. Dudley is also a board-certified toxicologist.
Steven A. Bourne, CPA, has served as our Chief Financial Officer, Secretary and Treasurer since February 2004. Prior to that, from January 2002 to May 2003, he served as Chief Financial Officer, Secretary and Treasurer at Anagen Therapeutics, Inc. He served as Controller, Secretary and Treasurer of Aksys, Ltd., a public company during his tenure from 1996 to 2001. Mr. Bourne received his B.S. in Accounting from Miami University and is a Certified Public Accountant.
Stanley C. Penzotti, Jr., Ph.D., has served as our Vice President, Pharmaceutical Development since June 2006. Prior to joining us, from 2004 to 2006, Dr. Penzotti was the Vice President of Product Development at AAI Pharma, a contract research organization. Dr. Penzotti was the Executive Director of Pharmaceutical and Analytical Sciences at Pharmacia/Searle from 1995 to 2002. He received his B.S. from the University of Michigan and his Ph.D. in Pharmaceutics from the University of North Carolina, Chapel Hill.